BioElectronics Announces Independent Migraine Clinical Study; Migraine Prevention Using ActiPatch (Pulsed Shortwave Therapy)

Press Release BioElectronics Announces Independent Migraine Clinical Study; Migraine Prevention Using ActiPatch (Pulsed Shortwave Therapy)

FREDERICK, MD, May 30, 2017 (Marketwired via COMTEX) — FREDERICK, MD–(Marketwired – May 30, 2017) – BioElectronics Corporation (otc pink:BIEL), www.bielcorp.


Read all

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.